Dermatitis D003872

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Dermatitis

Description

Any inflammation of the skin.   MeSH

Subtype Terms (13)

Acrodermatitis
 

Dandruff
 

Dermatitis, Atopic
346 drugs (103 approved, 243 experimental)

Dermatitis, Contact
19 drugs (10 approved, 9 experimental)

Dermatitis, Exfoliative
3 approved drugs

Dermatitis Herpetiformis
9 drugs (7 approved, 2 experimental)

Dermatitis, Perioral
3 approved drugs

Dermatitis, Seborrheic
29 drugs (19 approved, 10 experimental)

Drug Eruptions
 

Eczema
111 drugs (48 approved, 63 experimental)

Intertrigo
3 approved drugs

Neurodermatitis
6 drugs (4 approved, 2 experimental)

Radiodermatitis
31 drugs (11 approved, 20 experimental)


Phase 4 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (82)

Organization Involved with Phase 3 Indications (78)

Organization Involved with Phase 2 Indications (189)

Organization Involved with Other Experimental Indications (72)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.